Corium Reports Second Quarter Fiscal 2018 Finaical Results and Corporate Highlights
MENLO PARK, Calif. , May 14, 2018 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited financial results for the second…